It has also been reported that DNA methylation is the reason for the downregulation of SPARCL1 and demethylation of the gene partially reversed the abnormal expression in pancreatic cancer [11] and osteosarcoma [12]. This evidence concerns the gene SPARCL1 and familial pancreatic carcinoma.